{"name":"Cullinan Therapeutics Inc.","slug":"cullinan-therapeutics-inc","ticker":"","exchange":"","domain":"cullinan.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTFB3bENLeUsyVWdTSlpNQXJOODBJZWhqVEtUN055emlWMHhWdE80c3QyRk5lS21pMlAwREZWR2p6RFo3Nklnend6ajk1UDY5WnBBNVE?oc=5","date":"2026-04-04","type":"pipeline","source":"Yahoo Finance Australia","summary":"ORIC Pharmaceuticals, Inc. (ORIC) stock price, news, quote and history - Yahoo Finance Australia","headline":"ORIC Pharmaceuticals, Inc. (ORIC) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxPRExnTFgta0Jpa2daWm9BRlFOeWJwNjZUNC1Ld3lLLUJkWDc1S283OUJ0WHhCSmhQdkpzT2UwSDJEeUxrdnVVaktsSy05TnZOcDNHaS1GczFFUnppSEhCbFlENnYwcFp5Smo4RGtpVTBvb1hzN2dvMUJlTEZPcFBKd0FjT0pVbHZBSDN2NzRFS2tNS3VURkhWeTdwdHl2eTFkX1o4bXZYNVM0OHl5S2F0bXRfc3Z2NmNvZUVFQWhuSXE2TXdRazh0REprOG5HaFpTUkxQQkM0eDUteFBGcm4xVnE0bEtwYnFKSWtMMWR5aDJibHV4R3dTNGRRWGN3ejAzUkVDMFhSd29JOXhVaVBuNTZCQWhkWnFFRlNnNjJha1U?oc=5","date":"2026-03-11","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI), Cullinan Management (CGEM) and Pfizer (PFE) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI), Cullinan Management (CGEM) and Pfizer (P","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugJBVV95cUxPRWdfN3g4NnRHX1lpcmV5UDljUy0zV0xWVGhGNUNZaFM4cEtwQWtjODBlSlp2MEpvaDgtUWVDTTVRUGxxNHpaSzRhbWY5QVJ6VWNvLUxiLW1sVVczYVEtdjJkcV9Ud1NmQ09FcFBiSlJuc2RwT3ZxSkpLZTRoV3RYZmhmWlFVZ3lNNHdQMnluNENjQ3V3d2czYmpOd2JQT0hROHNuWXpRVGtoRTZZZ3ktVExiY2VBZDJnWDlaOE9sRVJpY1h4TXp4TUlhaVlMY0ctY215dDVqckwxMHVJb2ZfdmNrZmstUk5YTFVFX191UUhHVVJ0V2RqMUZQc1ctcmVXMTE1ZHhhcXBUOWI1Ung1YXBaVnZCcGpic1dKMTU1NmNRaGhqYUVabFNDY0RsS0UxN0UxNVZmT3U0UQ?oc=5","date":"2026-01-24","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: Cullinan Management (CGEM), Ultragenyx Pharmaceutical (RARE) and Teva Pharmaceutical (TEVA) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: Cullinan Management (CGEM), Ultragenyx Pharmaceutical (RARE) and Teva P","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOTGVUc2hjcmZUbzVIbkZ3N0lxbFpzb2NnWXV2R2FFaS0tSlhKcWVuZU5zZXA0b0dGSkFJTzhlX3VsUlNxdHQ2X1dIdzVmSldYZll6NGZnY0tBaEl4c09oaUxTY3dwZ19reFhwQmk5cFhkQXBGT1B3cEdQeGVkQWo2UjhSVlhXRVhXYmlvUGpvSFJwYWs3OHQ1ei0yYkZxQ3dubDBTTi1yNA?oc=5","date":"2025-11-21","type":"trial","source":"BioWorld News","summary":"Taiho, Cullinan file rolling NDA on phase I/II zipalertinib data - BioWorld News","headline":"Taiho, Cullinan file rolling NDA on phase I/II zipalertinib data","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-20","type":"pipeline","source":"prnewswire.com","summary":"Taiho Oncology, Taiho Pharmaceutical and Cullinan Therapeutics Initiate Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Zipalertinib for Treatment of Locally Advanc","headline":"Taiho Oncology, Taiho Pharmaceutical and Cullinan Therapeutics Initiate Rolling Submission of New Drug Application to U.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPTEhsekF3MVZONFh5TjhBRmhVSHJBdU5YeXoyWmdKSVhJS2d5Wkx6Sm8yYzNtLW4wc1NfSF9jX1hoanJqQUtYWVUyU3RSaFZXN1AzUE1NZTB2VTdXbXZVaUpBWF9qdG14Zm45TUxybUtYbW9SRnNmM0lKaWd2TFJGREZmeElIdnZvd0FfUHRfMTMxSTBkamJKQzJQS2FyaVNnaDhuRjlHRG1adw?oc=5","date":"2025-11-06","type":"pipeline","source":"Fierce Biotech","summary":"Cullinan sidelines pair of oncology assets amid expansion into autoimmune R&D - Fierce Biotech","headline":"Cullinan sidelines pair of oncology assets amid expansion into autoimmune R&D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAJBVV95cUxQZGdtS2g1cmF5aWJwb1J1emNMVmdaRmlRNFBnNEpBRjVNLW96NjNhSUJGN3FOZHFfRGpwd2pCRTQyRW45ZV90aTZkVFQtSnprekJrM2NlWjZmNFpYNGVsOHRjdDNTWm05NTJySnBRNlQ0bnE1OWNudUZkM3dzVHpKYU8wSmRONDRqc3VuejI1TFJXUk04aUs0Ym9yQWIyNUZVVW1vLVRTWnJiVkNVNEVYVXFocWRrNWtlWHM2QlhlYnVlZHRpRkV5TkNwY3hZeEdieldkVHVPc3MwM1ZxV0RQaV8wNXpZajRDYW5JZXNOU3ZQMU5POHNYZzdkNWNEU0RRWXp5LUFJdmxMX0MxXzRBekMwdjN4bkZKZUhreWtlUk93YmVYSTdwaGcwazB0NnhXc1djYzcwOE1GUEdJNWZxVFV5OEk?oc=5","date":"2025-10-12","type":"trial","source":"prnewswire.com","summary":"Taiho Oncology and Cullinan Therapeutics Present Data on Zipalertinib in Patients with NSCLC with EGFR mutations and Active Brain Metastases at the ESMO Congress 2025 - prnewswire.com","headline":"Taiho Oncology and Cullinan Therapeutics Present Data on Zipalertinib in Patients with NSCLC with EGFR mutations and Act","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxPRjBNSGlSTG1MN1FSRlNpS2I2OEM2MElJRDlLZEc5MFZvcUxUZXJvd2ZRRWhkdktFci1XTmw4UU4tVENzc3pkUVpuQTRzQ3FTaEN0RkNmbnNCMzg0UWlQRWpQY1k2RnUyLWNwb1VvLVNmRk5scC0zTElEUGVFR0dyT0t6NWkzMW5vNzF1MVJfQWZNRjExdWhSUmtVUVlxUnNwNV9HdHVuX3RPTUNBVE9tQmdzeEotX256M24xOWx1WHJBMWFqbTBCU09kTENQREtaMzRINmNCWlRJMExlNV9rNE1HOGpoR1pERnA3SnllNXRLeHNSZmpackZPSFlaMnVkeUFFY1Zn?oc=5","date":"2025-09-09","type":"trial","source":"prnewswire.com","summary":"Taiho Oncology and Cullinan Therapeutics Present Data on Zipalertinib at the IASLC 2025 World Conference on Lung Cancer - prnewswire.com","headline":"Taiho Oncology and Cullinan Therapeutics Present Data on Zipalertinib at the IASLC 2025 World Conference on Lung Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE91NEtwRGtIQWJzVVhyNWd5YmxkaGxaMTJUMGlmWkNDUm9zMW5Hby1vS0tRVWFJdDYzYlFFai1TYnRSd2ZSdzZiT3VWdDFhSFNrS0g4TENESmkwVWloZk9TMHBTR2JfTV9H?oc=5","date":"2025-07-10","type":"regulatory","source":"MarketBeat","summary":"Cullinan Therapeutics (CGEM) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat","headline":"Cullinan Therapeutics (CGEM) FDA Approvals, PDUFA Dates & Drug Alerts 2026","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOOWFqUnA2eWoydEp1eXVIZERSMXBCZi1MYkUzNDU5Vl9RUWNSRUNGaGFCb0tCQmNVWkkzLVBQTFJlQndwR0xGdV80VmZHUjNGb0VxV29VMTdYMzZpbjQ1ZVdraUN2QlR0ay0zdnFuUmdheUczUW5YMDA2ZVJxTWlmdEtmLWNCVXFQelpLTGxPWW5aYWQ2a0E5dkRCU1pMeGVJMlZlUU5DY25ScVRjV1lGV3NpeWo?oc=5","date":"2025-06-05","type":"deal","source":"Contract Pharma","summary":"Cullinan Therapeutics Licenses Rights to Velinotamig from Genrix Bio - Contract Pharma","headline":"Cullinan Therapeutics Licenses Rights to Velinotamig from Genrix Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPelFsazlYUXRsMjRubHFuM3NrempvbDRuZFh4eGw2V01ncGx4Vy1kRThsQ21ZODRsakpaVHRkOTJvMUctRnNmS2dtd1liTWpsdzNQd2Vmdy0yNjNSY2FjUVRLbzhRWXBmaHhkbzlyTEhWcUtQV1JEZTJnNk1yNEI0ODZ6b3FHWUNiVkszTl9FNXNZZklYYms0T2tRZXdfdw?oc=5","date":"2025-06-05","type":"deal","source":"BioPharma Dive","summary":"Cullinan doubles down on bispecifics for autoimmune disease with Genrix deal - BioPharma Dive","headline":"Cullinan doubles down on bispecifics for autoimmune disease with Genrix deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wJBVV95cUxOMjc1ZUUxTTNLRElmYnctUnpKbGNLZ1RwTWpkWnFzS0NWRUhodUpCQV9LRWFUMHJ5T1o0WVQzeHdWVWF2NzREZDRPbWxQUkFDUFIxQ043bmZrWFlRaG1kQWU1Qjc4eEMweXEtUnVBOFNJZHZPN21LdGxoWXIxZlhxbk1rR0drN2o1NWhnM3BfbG1EOGJNdzhYQkxfRG1henZRVVllcVVOLVppSmxid2ZwMnB0VzdfLWRmNFU5Y2s4MG1HRlZ5eDM5MVBVSEp6ZmJtRnpIbUIwTjRxcWlUUTNjaGhtVDBFUFFXaElBYTUyRFlNZ05lTHVqUmhua2ZrREQ2Tlg2UFh6MnQ4Ty0zOC03azVrb3JoV3ZJVG4tblA2RndFeFNzWDNESmxKbHU2U0ZtbjVtVDdZMnFVMEF2TVlCNm0yOUtIUnZfTzg5NDhuaGNwLVR2QlpZ?oc=5","date":"2025-06-04","type":"deal","source":"GlobeNewswire","summary":"Cullinan Therapeutics Licenses Rights to Velinotamig, a - GlobeNewswire","headline":"Cullinan Therapeutics Licenses Rights to Velinotamig, a","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}